The Global Bleeding Disorders Treatment Market is expected to register a growth of significant CAGR 10.0% during the forecast period (2018–2023).
A bleeding disorder is a condition where there is a problem with the body’s clotting method. This disorder leads to heavy and protracted bleeding after an injury. The bleeding process can also start on its own. Most of the types of bleeding disorders are hereditary but some are acquired due to liver diseases, side effects of certain medications, low red blood cell count, vitamin K deficiency and others. The global bleeding disorders treatment market is expected to witness fast growth during the forecast period due to growth in the number of people suffering from liver diseases, anemia, and other blood coagulation disorders.
Segmentation
The global bleeding disorders treatment market has been segmented on the basis of type, drug class, treatment and end users.
On the basis of type, the market has been classified as hemophilia A, hemophilia B, Von Willebrand Disease (vWD) and others.
On the basis of drug class, the market has been classified as plasma-derived coagulation factor concentrates market, global recombinant coagulation factor concentrate market, global others bleeding disorders treatment market.
On the basis of treatment, the market has been classified as desmopressin (DDAVP), hormone replacement therapy, contraceptives, anti-fibrinolytic/clot-stabilizing drugs, fibrin sealants, drugs applied to cuts and pipeline analysis (phase I, phase II and phase III clinical trials)
On the basis of end users, the market has been classified as hospitals, clinics, specialty clinics, research institutes, and others.
Key Players
Some of the key players in the global bleeding disorders treatment market are Shire Plc, Bayer Pharmaceuticals, Novo Nordisk A/S, Pfizer Inc., Biogen Idec, CSL Behring, Grifols, Octapharma, Sun Pharmaceutical Industries Ltd., BDI Pharma, Ferring Pharmaceuticals, and others.
Global Bleeding Disorders Treatment Market, by Type
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease (vWD)
- Others
Global Bleeding Disorders Treatment Market, by Drug Class
- Plasma-derived coagulation factor concentrates market
- Global recombinant coagulation factor concentrate market
- Global others bleeding disorders treatment market
Global Bleeding Disorders Treatment Market, by Treatment
- Medication
- Desmopressin (DDAVP)
- Hormone replacement therapy
- Contraceptives
- Anti-fibrinolytic/clot-stabilizing drugs
- Fibrin sealants
- Drugs applied to cuts
- Pipeline analysis (phase I, phase II and phase III clinical trials)
Global Bleeding Disorders Treatment Market, by End-Users
- Hospitals
- Clinics
- Research Institutes
- Others
Request Customization
Get a Sample
Get a Sample
Request Customization